Alignment Healthcare, Inc. $ALHC Shares Acquired by Granahan Investment Management LLC

Granahan Investment Management LLC lifted its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 4.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 780,500 shares of the company’s stock after acquiring an additional 31,013 shares during the quarter. Granahan Investment Management LLC owned 0.38% of Alignment Healthcare worth $13,752,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Summit Securities Group LLC purchased a new position in Alignment Healthcare in the fourth quarter worth approximately $26,000. Parallel Advisors LLC increased its position in shares of Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare in the 3rd quarter valued at $33,000. First Horizon Corp acquired a new stake in shares of Alignment Healthcare in the 4th quarter valued at $39,000. Finally, GAMMA Investing LLC lifted its position in shares of Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $16.09, for a total value of $482,700.00. Following the sale, the president owned 998,813 shares in the company, valued at $16,070,901.17. This represents a 2.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider owned 331,750 shares in the company, valued at $6,588,555. This represents a 9.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,039,951 shares of company stock worth $19,976,967. Insiders own 5.20% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on ALHC. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Wolfe Research assumed coverage on Alignment Healthcare in a research report on Friday, April 17th. They set an “outperform” rating and a $24.00 target price on the stock. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Finally, Barclays lowered their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Six equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $19.43 on Friday. Alignment Healthcare, Inc. has a one year low of $11.66 and a one year high of $25.12. The stock has a market capitalization of $4.02 billion, a price-to-earnings ratio of 215.89, a PEG ratio of 2.70 and a beta of 1.05. The company has a 50-day simple moving average of $19.57 and a 200-day simple moving average of $19.87. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. During the same quarter last year, the company posted ($0.05) earnings per share. The business’s revenue was up 33.3% on a year-over-year basis. On average, analysts predict that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.